Your browser doesn't support javascript.
loading
Extreme chromosomal instability forecasts improved outcome in ER-negative breast cancer: a prospective validation cohort study from the TACT trial.
Jamal-Hanjani, M; A'Hern, R; Birkbak, N J; Gorman, P; Grönroos, E; Ngang, S; Nicola, P; Rahman, L; Thanopoulou, E; Kelly, G; Ellis, P; Barrett-Lee, P; Johnston, S R D; Bliss, J; Roylance, R; Swanton, C.
Afiliación
  • Jamal-Hanjani M; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London.
  • A'Hern R; ICR-CTSU, Division of Clinical Studies, The Institute of Cancer Research, London.
  • Birkbak NJ; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London The Francis Crick Institute, 44 Lincoln's Inn Fields, London.
  • Gorman P; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London.
  • Grönroos E; The Francis Crick Institute, 44 Lincoln's Inn Fields, London.
  • Ngang S; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London.
  • Nicola P; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London.
  • Rahman L; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London.
  • Thanopoulou E; The Francis Crick Institute, 44 Lincoln's Inn Fields, London.
  • Kelly G; The Francis Crick Institute, 44 Lincoln's Inn Fields, London.
  • Ellis P; Guy's and St Thomas' NHS Trust, London.
  • Barrett-Lee P; Velindre NHS Trust, Cardiff.
  • Johnston SR; Royal Marsden NHS Foundation Trust, London.
  • Bliss J; ICR-CTSU, Division of Clinical Studies, The Institute of Cancer Research, London.
  • Roylance R; Barts Cancer Institute, Queen Mary University of London, London, UK r.roylance@qmul.ac.uk charles.swanton@crick.ac.uk.
  • Swanton C; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London The Francis Crick Institute, 44 Lincoln's Inn Fields, London.
Ann Oncol ; 26(7): 1340-6, 2015 Jul.
Article en En | MEDLINE | ID: mdl-26003169
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Protocolos de Quimioterapia Combinada Antineoplásica / Receptores de Estrógenos / Biomarcadores de Tumor / Inestabilidad Cromosómica Tipo de estudio: Clinical_trials / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Middle aged Idioma: En Revista: Ann Oncol Asunto de la revista: NEOPLASIAS Año: 2015 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Protocolos de Quimioterapia Combinada Antineoplásica / Receptores de Estrógenos / Biomarcadores de Tumor / Inestabilidad Cromosómica Tipo de estudio: Clinical_trials / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Middle aged Idioma: En Revista: Ann Oncol Asunto de la revista: NEOPLASIAS Año: 2015 Tipo del documento: Article